201 related articles for article (PubMed ID: 24382030)
1. The effect of antihypertensive agents on sleep apnea: protocol for a randomized controlled trial.
Cichelero FT; Martinez D; Fuchs SC; Gus M; Moreira LB; Fuchs FD
Trials; 2014 Jan; 15():1. PubMed ID: 24382030
[TBL] [Abstract][Full Text] [Related]
2. Effect of antihypertensive agents on sleep apnea and ambulatory blood pressure in patients with hypertension: A randomized controlled trial.
Cichelero FT; Fuchs SC; Jorge JA; Martinez D; Oliveira GPF; Lucca MB; Oliveira ACT; Fuchs FD
Sleep Med; 2024 Jul; 119():417-423. PubMed ID: 38781664
[TBL] [Abstract][Full Text] [Related]
3. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
[TBL] [Abstract][Full Text] [Related]
4. A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial.
Fuchs FD; Fuchs SC; Moreira LB; Gus M; Nóbrega AC; Poli-de-Figueiredo CE; Mion D; Bortolotto L; Consolim-Colombo F; Nobre F; Coelho EB; Vilela-Martin JF; Moreno H; Cesarino EJ; Franco R; Brandão AA; de Sousa MR; Ribeiro AL; Jardim PC; Afiune Neto A; Scala LC; Mota M; Chaves H; Alves JG; Sobral Filho DC; Pereira e Silva R; Figueiredo Neto JA; Irigoyen MC; Castro I; Steffens AA; Schlatter R; de Mello RB; Mosele F; Ghizzoni F; Berwanger O
Trials; 2011 Feb; 12():53. PubMed ID: 21349192
[TBL] [Abstract][Full Text] [Related]
5. Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension.
Litvin AY; Sukmarova ZN; Elfimova EM; Aksenova AV; Galitsin PV; Rogoza AN; Chazova IE
Vasc Health Risk Manag; 2013; 9():229-35. PubMed ID: 23690688
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.
Payeras AC; Sladek K; Lembo G; Alberici M
Clin Drug Investig; 2007; 27(9):623-32. PubMed ID: 17705571
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial.
Martins VM; Helal L; Ferrari F; Bottino LG; Fuchs SC; Fuchs FD
Trials; 2019 Dec; 20(1):736. PubMed ID: 31843024
[TBL] [Abstract][Full Text] [Related]
8. Effects of chlorthalidone plus amiloride compared with amlodipine on short-term blood pressure variability in individuals with hypertension and obstructive sleep apnea: a randomized controlled trial.
Lucca MB; Jorge JA; Cichelero FT; Martinez D; Borges RB; Hirakata VN; Fuchs FD; Fuchs SC
Blood Press Monit; 2023 Dec; 28(6):289-294. PubMed ID: 37466401
[TBL] [Abstract][Full Text] [Related]
9. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
[TBL] [Abstract][Full Text] [Related]
10. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Cushman WC; Ford CE; Einhorn PT; Wright JT; Preston RA; Davis BR; Basile JN; Whelton PK; Weiss RJ; Bastien A; Courtney DL; Hamilton BP; Kirchner K; Louis GT; Retta TM; Vidt DG;
J Clin Hypertens (Greenwich); 2008 Oct; 10(10):751-60. PubMed ID: 19090876
[TBL] [Abstract][Full Text] [Related]
12. Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
Zappe D; Papst CC; Ferber P;
Vasc Health Risk Manag; 2009; 5():883-92. PubMed ID: 19898644
[TBL] [Abstract][Full Text] [Related]
13. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Virolainen J; Kontula K
Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745
[TBL] [Abstract][Full Text] [Related]
14. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
15. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
[TBL] [Abstract][Full Text] [Related]
16. [Established blood pressure drug wins out in a comparative study. In hypertension, a diuretic first!].
Wepner U
MMW Fortschr Med; 2003 Jan; 145(1-2):10-2. PubMed ID: 12638431
[No Abstract] [Full Text] [Related]
17. Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study.
Lynch AI; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
Pharmacogenet Genomics; 2009 Jun; 19(6):415-21. PubMed ID: 19352213
[TBL] [Abstract][Full Text] [Related]
18. Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial.
Fuchs FD; Fuchs SC; Moreira LB; Gus M; Nóbrega AC; Poli-de-Figueiredo CE; Mion D; Bortoloto L; Consolim-Colombo F; Nobre F; Coelho EB; Vilela-Martin JF; Moreno H; Cesarino EJ; Franco R; Brandão AA; de Sousa MR; Ribeiro AL; Jardim PC; Neto AA; Scala LC; Mota M; Chaves H; Alves JG; Filho DC; Pereira e Silva R; Neto JA; Irigoyen MC; Castro I; Steffens AA; Schlatter R; de Mello RB; Mosele F; Ghizzoni F; Berwanger O
Trials; 2011 Mar; 12():65. PubMed ID: 21375762
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.
Punzi H; Neutel JM; Kereiakes DJ; Shojaee A; Waverczak WF; Dubiel R; Maa JF
Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):209-21. PubMed ID: 20519261
[TBL] [Abstract][Full Text] [Related]
20. Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: A Randomized Crossover Trial.
Moes AD; Hesselink DA; van den Meiracker AH; Zietse R; Hoorn EJ
Am J Kidney Dis; 2017 Jun; 69(6):796-804. PubMed ID: 28259499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
